TiVi Evaluation of Microcirculatory Reactivity of the Skin to Galvanic Stimulation: Effect of Aspirin

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 830 participants.

Also called NCT03357367

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 830 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03357367
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
France (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03357367. Allocation not applicable; no masking; primary purpose treatment. Start 2018-02-08 (actual); primary completion 2021-09-26 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
TiVi Evaluation of Microcirculatory Reactivity of the Skin to Galvanic Stimulation: Effect of Aspirin
Acronym
PIRAAT
Condition
Peripheral Arterial Disease
Intervention (Device)
TiVi system
Lead sponsor
University Hospital, Angers (class: other government)

Record details

Record id
cardio:ct-nct03357367
Content hash
9f42790bc3d9f9c240f497e14f03bac29dcec3c6a535d5bcee36447ca90eb8fa